Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
J Diet Suppl ; 10(4): 391-431, 2013 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-24237193

RESUMO

An evidence-based systematic review of bitter orange (Citrus aurantium) by the Natural Standard Research Collaboration consolidates the safety and efficacy data available in the scientific literature using a validated, reproducible grading rationale. This article includes written and statistical analysis of clinical trials, plus a compilation of expert opinion, folkloric precedent, history, pharmacology, kinetics/dynamics, interactions, adverse effects, toxicology, and dosing.


Assuntos
Citrus , Fitoterapia , Extratos Vegetais/uso terapêutico , Comportamento Cooperativo , Medicina Baseada em Evidências , Humanos , Extratos Vegetais/administração & dosagem , Extratos Vegetais/farmacologia
2.
J Diet Suppl ; 10(3): 264-308, 2013 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-23931762

RESUMO

An evidence-based systematic review of active hexose correlated compound (AHCC) by the Natural Standard Research Collaboration consolidates the safety and efficacy data available in the scientific literature using a validated, reproducible grading rationale. This article includes written and statistical analysis of clinical trials, plus a compilation of expert opinion, folkloric precedent, history, pharmacology, kinetics/dynamics, interactions, adverse effects, toxicology, and dosing.


Assuntos
Adjuvantes Imunológicos/uso terapêutico , Basidiomycota/química , Produtos Biológicos/uso terapêutico , Suplementos Nutricionais , Glucanos/uso terapêutico , Fitoterapia , Polissacarídeos/uso terapêutico , Adjuvantes Imunológicos/efeitos adversos , Adjuvantes Imunológicos/farmacologia , Animais , Produtos Biológicos/efeitos adversos , Produtos Biológicos/farmacologia , Medicina Baseada em Evidências , Glucanos/efeitos adversos , Glucanos/farmacologia , Humanos , Polissacarídeos/efeitos adversos , Polissacarídeos/farmacologia
3.
Cancer Metastasis Rev ; 32(1-2): 201-10, 2013 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-23090260

RESUMO

Angiogenesis is a necessary step in tumor growth and metastasis. It is well established that the metabolites of omega-6 and omega-3 fatty acids, which must be obtained through the diet and cannot be synthesized de novo in mammals, have differential effects on cellular processes. Omega-6 fatty acid (n-6 FA)-derived metabolites promote angiogenesis by increasing growth factor expression whereas omega-3 fatty acids (n-3 FA) have anti-angiogenic and antitumor properties. However, most studies thus far have failed to account for the role of the n-6 FA/n-3 FA ratio in angiogenesis and instead examined the absolute levels of n-6 and n-3 FA. This review highlights the biochemical interactions between n-6 and n-3 FA and focuses on how the n-6/n-3 FA ratio in tissues modulates tumor angiogenesis. We suggest that future work should consider the n-6/n-3 FA ratio to be a key element in experimental design and analysis. Furthermore, we recommend that clinical interventions should aim to both reduce n-6 metabolites and simultaneously increase n-3 FA intake.


Assuntos
Ácidos Graxos Ômega-3/metabolismo , Ácidos Graxos Ômega-6/metabolismo , Neoplasias/irrigação sanguínea , Neoplasias/metabolismo , Neovascularização Patológica/metabolismo , Animais , Modelos Animais de Doenças , Humanos , Camundongos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA